Избирательная токсичность. Физико-химические основы терапии Том 2 - Альберт А.
ISBN 412-26010-7
Скачать (прямая ссылка):
Browning C., Gulbransen R., Kennaway E., Thornton L. — Brit. Med. J., 1917, i„ p. 73.
Bruiee T., Benkovie S. Bioorganic Mechanisms (2 vols). — New York, Benjamin, 1966.
Bruni J., Wilder B. — Arch. Neurol., 1979, vol. 36, p. 393.
Bryan L., Van den Elzen H. — Antimicrob. Agents Chemother., 1977, vol. 12, p. 163.
Bryan S., Frieden E. — Biochemistry, 1967, vol. 6, p. 2728.
Buchanan J- — In: Chemistry and Biology of Purines/Eds. G. Wolstenholme;
C. O'Connor, London: Churchill, 1957, p. 233. Buchanan J. — In: Enzyme-Activated Irreversible Inhibitors/Eds. N. Seiler,
M. Jung, J. Koch-Weser, Amsterdam: North Holland, 1978. Buchel К, Draber W. — Progr. Photosyn. Res., 1969, vol. 3, p. 1777. Bueding E., Batzinger R.. Cha Y. et al. — Pharmacol. Rev., 1979, vol. 3? p. 547.
Bukatsch F., Haitinger M. — Protoplasma, 1940, vol. 34, p. 515.
Bulbring E., Tomita Т. — Proc. Roy. Soc. В, 1969, vol. 172, p. 103.
Bullen /., Rogers Я. — Nature, Lond., 1969, vol. 224, p. 380.
Bunting J., Meathrel W. — Canad. J. Chem., 1972, vol. 50, p. 917.
Burchall J. — Fed. Proc., 1966, vol. 25, p. 277.
Burchall /., Hitchings G. — Molec. Pharmacol., 1965, vol. 1, p. 126.
Burgen A. — Brit. J. Pharmacol. Chemother., 1965, vol. 25, p. 4.
Burgen A., Standridge R., Ariens E. — J. Med. Chem., 1963, vol. 6, p. 221.
Burger A.t Standridge R.? Stjernstrom N., Marchini P. — J. Med. Pharm. Chem.,
1961, vol. 4, p. 517. Burn J., Dale H. — J. Pharmacol., 1915, vol. 6, p. 417.
Burns /., Yu T., Dayton P. et al. — Ann. N.Y. Acad. Sci., 1960, vol. 86, p. 25? Burtt E.— Ann. Appi. Biol., 1945, vol. 32, p. 247.
Butler H., Hurse A., Thursky E., Shulman A. — Austral. J, Exper. Biol. Med.
Sci., 1969, vol. 47, p. 541. Butler Т. — J. Pharmacol., 1944, vol. 81, p. 72. Butler T. — Pharmacol. Rev., 1950, vol. 2, p. 121. Buttlerworth /., Eley D., Stone G. —Biochem. J., 1953, vol. 53, p. 30. Byrde R., Woodcock D. — Nature, Lond., 1957, vol. 179, p. 539. Byrn S., Graber C., Midland S. — J. Org. Chem., 1976, vol. 41, p. 2283. Cade J. — Med. J. Austral., 1949, vol. 36, p. 349. Cahn R. —J. Chem. Educ., 1964, vol. 41, pp. 116, 503.
Cahn R., Dermer 0. Introduction to Chemical Nomenclature 5th edn. — London:
Butterworths1 1979. Cahn R., Ingold C., Prelog V. — Experientia, 1956, vol. 12, p. 81. Cairns /. — Cold Spring Harbor Symp. Quant. Biol., 1962, vol. 27, p. 311. Cairns J. — Sei. Amer., 1975, vol. 233, p. 64.
392" Calvert A., Harland S., Newell D, et al. — Cancer Chemother. Pharmacol., 1982, vol. 9, p. 140.
Calvin M., Wilson K. — S. Amer. Chem. Soc., 1945, vol. 67, p. 2003.
Cammarata A., Yau S., Collett J., Martin A. — Molec. Pharmacol., 1970, vol. 6, p. 61.
Camp H., Fukoto T., Metcalf R. — S. Agric. Food Chem., 1969, vol. 17, p. 243.
Campbell /., Dobson D. — Methods Biochem. Anal., 1979, vol. 25, p. 1.
Canellakis E., Bono V., Bellantone A. et at. — Biochim. Biophys. Acta, 1976, vol. 418, p. 300.
Сапера F., Pauling P., Sorum H. — Nature, Lond., 1966, vol. 210, p. 907.
Canfield C., Rozman R. — Bull. World Health Org., 1974, vol. 50, p. 203.
Cantley L., Resh M., Guidotti G. — Nature, Lond., 1978, vol. 272, p. 552.
Caranikas S., Mizrahi /., Escher E., Regoli D. — J. Med. Chem., 1982, vol. 25, p. 1313.
Carlsson A., Lundqvist M. — Acta Pharmacol. Toxicol., 1963, vol. 20, p. 140.
Carlstrom D., Bergin R. — Acta Crystallogr., 1967, vol. 23, p. 313.
Carmenier G. — Biochem. Pharmacol., 1968, vol. 17, p. 1981.
Caroon J., Clark R., Kluge A. et al. — S. Med. Chem., 1982, vol. 25, p. 666.
Carson S. — Biochem. Pharmacol., 1982, vol. 31, p. 1806.
Carter S., Friedman M. — Eur. J. Cancer, 1972, vol. 8, p. 85.
Carter S., Sakurai Y., Umezawa H. (eds.). New Drugs in Cancer Chemotherapy. — New York: Springer, 1981.
Casida 3., McBryde L., Niedermeir R. — S. Agric. Food Chem., 1962, vol. 10, p. 370.
Casselton P. —Nature, Lond., 1964, vol. 204, p. 93.
Castagna M., Takai Y., Kaibuehi K. et al. — S. Biol. Chem., 1982, vol. 257, p. 7847.
Casy A. PMR Spectroscopy in Medicinal and Biological Chemistry. — London: Academic Press, 1971.
Casy A., Ison R. — J. Pharm. Pharmacol., 1970, vol. 22, p. 270.
Cattell W., Chamberlain D., Fry I. et al. — Brit. Med. J., 1971, i, p. 377.
Cawthon R., Breakefield X. — Nature, Lond., 1979, vol. 281, p. 692.
Cederbaum D. — New Engl. J. Med., 1979, p. 301.
Cha i„ Agarwal R., Parks R. — Biochem. Pharmacol., 1975, vol. 24, p. 2187.
Chacko G., Villegas G., Barnola F. et al. — Biochim. Biophys. Acta, 1976, vol. 443, p. 19.
Chambron /., Daune M., Sadron C. — Biochim. Biophys. Acta, 1966, vol. 123, pp. 306, 319.
Chang K, Hazum E., Kilian A., Cuatrecasas P. — Molec. Pharmacol., 1981, vol. 1, p. 20.
Chapman N., Shorter J. Advances in Free Energy Relationships. — London: Plenum Press, 1972.
Chen R., Kraemer C„ Sehmidmayr W. et al. — Biochem. J., 1982, vol. 203, p. 33.
Cheng C., Fugimura S., Grunberger D., Weinstein I. — Cancer Res., 1972, vol. 32, p. 22.
